Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Infectious Disease And Molecular Diagnostics Conference: Bringing Together Thought Leaders And Innovators

This image opens in the lightbox

News provided by

MarketsandMarkets

12 May, 2023, 15:30 GMT

Share this article

Share toX

Share this article

Share toX

CHICAGO, May 12, 2023 /PRNewswire/ -- MarketsandMarkets Conferences is a leading organizer of global conferences and events in the fields of Pharma, Healthcare, and Life Sciences. We are delighted to announce our forthcoming Infectious Disease and Molecular Diagnostics Conference, which is scheduled to take place in Boston, USA, on 19th-20th October 2023. The event will bring together industry experts, researchers, and key decision-makers to discuss the latest advancements, challenges, and opportunities in the field of infectious disease and molecular diagnostics.

With a focus on delivering high-quality and informative content, our conferences provide a platform for industry leaders, decision-makers, and experts to network, share knowledge, and discuss the latest developments in their respective fields.

One of the key highlights of the conference is the opportunity for international speakers to share their insights and expertise on various topics related to infectious disease and molecular diagnostics. The event offers an excellent platform for thought leaders to showcase their research and discuss their findings with a diverse audience.

As a speaker at the conference, participants will have the chance to network with fellow professionals from various fields and gain exposure to potential collaborators and investors. In addition, speakers will have the opportunity to interact with key decision-makers from the pharmaceutical and biotechnology industries, academic institutions, and government agencies.

MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference will cover a range of topics, including:

  • Implementation and Interpretation of Advanced Molecular Diagnostics
  • Reimaging Diagnostics with Smart Technologies
  • Tailoring Models and Advancements Under Infectious Disease Diagnostics Point of Care Testing
  • Promising Diagnostic Techniques in The Era of Consolidation
  • Future Molecular Diagnostics and New Diagnostic Technologies
  • Shaping The Point of Care Era with the Best Tools and Methodologies

The conference will also include panel discussions, workshops, and networking sessions.

For speaking opportunities, please write us at events@marketsandmarkets.com | cnc@mnmconferences.com.

The event is expected to attract a wide range of participants, including researchers, clinicians, laboratory professionals, and industry executives from around the world. With a focus on the latest developments and trends in the field, the conference promises to be an excellent opportunity for attendees to expand their knowledge and stay up to date with the latest industry insights.

In addition to the speaking opportunities, the conference also offers sponsorship and exhibition opportunities for companies looking to showcase their products and services to a diverse audience. This is an excellent chance for companies to interact with industry experts, establish new partnerships, and gain valuable exposure to potential clients and investors.

MarketsandMarkets is well-known for its expertise in the market research and consulting industry. With a team of experienced professionals and a global network of partners, the company has established itself as a trusted source of market intelligence and insights. The Infectious Disease and Molecular Diagnostics Conference is the latest addition to the company's portfolio of events, and it promises to be a highly informative and engaging event for all participants.

In conclusion, the MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference is an excellent opportunity for international speakers to showcase their research, network with fellow professionals, and gain valuable exposure to potential collaborators and investors. With a focus on the latest developments and trends in the field, the conference promises to be a highly informative and engaging event for all participants. We look forward to welcoming you to Boston in October 2023!

REGISTRATION STARTED - BLOCK YOUR CALENDAR TODAY!

About MarketsandMarkets™ Conferences

MarketsandMarkets™ Conferences is a global leader in organizing B2B conferences, summits, and corporate events. Our events provide a platform for industry leaders, decision-makers, and experts to network, share knowledge, and discuss the latest developments in their respective fields. We cover a wide range of industries, including Pharma, Healthcare, Biotechnology, Information Technology, and many more. Our events are attended by excellent delegates from around the world, including Fortune 500 companies, SMEs, startups, and more.

Our conferences are focused on delivering high-quality and informative content, and we bring together leading experts from academia, industry, and government to share insights and best practices, discuss challenges and opportunities, and explore emerging trends and technologies.

At MarketsandMarkets Conferences, we are committed to providing our attendees with the most valuable and informative experience possible. We strive to create an environment that encourages collaboration, innovation, and thought leadership, and we are dedicated to delivering events that exceed our attendees' expectations. Join us at our next conference and discover the latest trends, innovations, and best practices in your industry.

To find out more, visit www.events.marketsandmarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact: 
Ms. Nayantara Patil
MarketsandMarkets™ Conferences 
Tower B5, Office 101,
Magarpatta SEZ Hadapsar,
Pune - 411013,
India: +91 20 48598285

Email : events@marketsandmarkets.com

For more information about the MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference, visit the conference website or contact Marketing-CNC directly.

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

Modal title

Also from this source

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Open Gear Lubricant Quadrant Report 2025

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Open Gear Lubricant Quadrant Report 2025

360Quadrants has released its latest Open Gear Lubricant Startups/SMEs Companies Assessment, 2025, recognizing key players, including both global...

Infusion Pump Market worth US$28.3 billion by 2030 with 7.4% CAGR | MarketsandMarkets™.

Infusion Pump Market worth US$28.3 billion by 2030 with 7.4% CAGR | MarketsandMarkets™.

The global Infusion Pump Market, valued at US$18.5 billion in 2024 stood at US$19.9 billion in 2025 and is projected to advance at a resilient CAGR...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Infection Control

Infection Control

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.